GSK-Beer confirmed the effectiveness of COVID-19 treatment Promotion of emergency approval by the US FDA
[종합] Celltrion reduces the incidence of critically ill patients by 54% in phase 2 clinical trials of corona antibody treatment… Recovery period ↓
Medical Hyuppean News-Ministry of Food and Drug Safety shortens the review period for corona vaccines and treatments…’180 days → 40 days’
![[종합] Celltrion reduces the incidence of critically ill patients by 54% in phase 2 clinical trials of corona antibody treatment… Recovery period ↓](https://image.ajunews.com/content/image/2021/01/13/20210113235100686144.jpg "[종합] Celltrion reduces the incidence of critically ill patients by 54% in phase 2 clinical trials of corona antibody treatment… Recovery period ↓")
